anticoagulation.com

Home Contact Us Search

Home
Contents
INRstar
Training
Technical Support
Resources
Policies   

Home >> Resources >> Academic papers

Academic papers

This page contains links to papers and articles relevant to anticoagulation.

If you know of an additional paper or article that you think we should include, please send details.

Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation

Margaret C. Fang, MD, MPH; Yuchiao Chang, PhD; Elaine M. Hylek, MD, MPH; Jonathan Rosand, MD; Steven M. Greenberg, MD, PhD; Alan S. Go, MD; and Daniel E. Singer, MD
Annals of Internal Medicine; 16 November 2004; Volume 141 Issue 10, 745-752

Guidelines on oral anticoagulation: Third Edition.

British Journal of Haematology 1998; 101, 374-387

 

Investigation and management of heritable thrombophilia.

British Journal of Haematology 2001; 114(3), 512-528

 

INRs and point of care testing

E T Murray,  M Greaves. 

BMJ 2003;327:5-6 (5 July)

 

Anticoagulation in hospitals and general practice

Andrew D Blann, David A Fitzmaurice, Gregory Y H Lip. 

BMJ 2003;326:153-156

 

Oral anticoagulation and risk of death: a medical record linkage study

Anders Odén , Martin Fahlén

BMJ 2002;325:1073-1075

Return to top

Policy dilemmas for oral anticoagulation management.
D A Fitzmaurice, J P Rafferty and S Bryan
BJGP Oct 2000; Vol50 #459: 779-780

Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.
Lalit Kalra, Gloria Yu, Inigo Perez, Anil Lakhani, and Nora Donaldson
BMJ 2000; 320: 1236-1239

Anticoagulation for patients with atrial fibrillation and risk factors for stroke.
Stuart J Connolly
BMJ 2000; 320: 1219-1220

 

Using anticoagulation or aspirin to prevent stroke.
Simon J Ellis, Renu Hans, Jonathan Mant, David Fitzmaurice, Ellen Murray, Richard Hobbs, Andy Evans, Iñigo Perez, Lallit Kalra, Frans H Rutten, Eelko Hak, Arno W Hoes, P E Rose, Fiona Clair Taylor, Shah Ebrahim, Beppie Hellemons, Machteld Langenberg, Jan van Ree, André Knottnerus, Jan Lodder, Frank Vermeer, and Hubert Schouten
BMJ 2000; 320: 1008

 

Computer support for determining drug dose: systematic review and meta-analysis.
Robert Walton, Susan Dovey, Emma Harvey, and Nick Freemantle
BMJ 1999; 318: 984-990
 

Fortnightly review: Anticoagulation in heart disease.
Suzanna M C Hardman and Martin R Cowie
BMJ 1999; 318: 238-244

Return to top

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.
Alistair Howitt and David Armstrong
BMJ 1999; 318: 1324-1327

 

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
B S P Hellemons, M Langenberg, J Lodder, F Vermeer, H J A Schouten, Th Lemmens, J W van Ree, and J A Knottnerus
BMJ 1999; 319: 958-964

 

Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation Stroke.
L. Kalra, I. Perez, and A. Melbourn
Stroke 1999 30: 1218-1222

Doctors and patients must decide together whether anticoagulation is appropriate.
A J Howitt
BMJ 1998; 317: 210

 

Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment.
Richard Thomson, Helen McElroy, and Mark Sudlow
BMJ 1998; 316: 509-513
 

Impact of Atrial Fibrillation on the Risk of Death : The Framingham Heart Study Circulation.
Emelia J. Benjamin, Philip A. Wolf, Ralph B. D'Agostino, Halit Silbershatz, William B. Kannel, and Daniel Levy
Circulation 1998 98: 946-952

Return to top

Comorbidity increases benefit of anticoagulation in patients with atrial fibrillation.
Stephen Morgan
BMJ 1997; 314: 978


Evaluation of a decision support system for initiation and control of oral anticoagulation in a randomised trial.
B Vadher, D L H Patterson, and M Leaning
BMJ 1997; 314: 1252

 

Stroke prevention in atrial fibrillation.
Tim Lancaster, Jonathan Mant, and Daniel E Singer
BMJ 1997; 314: 1563

 

Warfarin use in patients with atrial fibrillation.
David Sulch, Stephen Bridger, Mark Sudlow, Helen Rodgers, Rose Anne Kenny, and Richard Thomson
BMJ 1997; 315: 750
 

Monitoring oral anticoagulation in primary care.
D A Fitzmaurice, F D R Hobbs, and J A Murray
BMJ 1996; 312: 1431-1432

Managing the increased workload in anticoagulant clinics.
D A Fitzmaurice, P E Rose, and M Gilbert
BMJ 1996; 312: 1226.

Return to top

Monitoring oral anticoagulation in primary care.
D I Gozzard and Alison Craig
BMJ 1996; 313: 818

Warfarin should be available as 0.5 mg tablet.
G Rouse, J Pope, and R G Dalton
BMJ 1996; 313: 50

Quality of service provision for anticoagulation in atrial fibrillation.
Adrian Edwards and Poisin Pill
BMJ 1996; 312: 51

How To Do It: Commentary: Caution needed in introducing warfarin treatment.
K G Sweeney, D J Pereira Gray, R J F Steele, and P H Evans
BMJ 1995; 311: 560-561


Anticoagulation in patients with atrial fibrillation GPs struggle to meet demand.
J Shakespeare, D A Fitzmaurice, F D R Hobbs, and E Murray
BMJ 1994; 308: 415

Antithrombolytics and stroke in AF.
Bandolier

Return to top

 

Questions or problems regarding this web site should be directed to webmaster
Copyright © 2002-2009 Sullivan Cuff Software Limited. All rights reserved.

Terms of use
This page was last updated on: Wednesday, 02 January 2008.